MMMaria Mappoura
Maria Mappoura
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Mappoura has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Federica Giannotti
Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland
3 shared publications- Carmen de Ramon Ortiz
Division of Hematology Department of Oncology Geneva University Hospitals Geneva Switzerland
2 shared publications Caroline Stephan
Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland
2 shared publicationsElif Mahne
Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland
2 shared publications- Stavroula Masouridi-Levrat
Division of Hematology, Department of Oncology, Geneva University Hospitals, 1205 Geneva, Switzerland
2 shared publications - Yan Beauverd
Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland
2 shared publications
Latest Publications
- 9 March 2024
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (6) , 893-895
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC
- 9 March 2024
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (6) , 893-895
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC
- Open Access
- 8 August 2022
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 28 (11) , 765.e1-765.e9
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study
- 8 August 2022
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 28 (11) , 765.e1-765.e9
Open AccessDefibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study
- Open Access
- 1 January 2021
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 27 (1) , 67.e1-67.e7
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts
- 1 January 2021
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 27 (1) , 67.e1-67.e7
Open AccessEvaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts